$OVTZ
OCULUS VISIONTECH INC.

2020 Q3 Form 10-Q Financial Statement

#000143774920023178 Filed on November 09, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $83.61K $31.36K $43.10K
YoY Change 93.99% -64.63% 65.86%
% of Gross Profit
Research & Development $93.27K $0.00
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $176.9K $31.36K $43.10K
YoY Change 310.4% -65.77% 65.86%
Operating Profit -$297.0K -$43.10K
YoY Change 589.06% 65.86%
Interest Expense $0.00 $170.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $3.310K $281.00
YoY Change -100.0%
Pretax Income -$297.0K -$27.88K
YoY Change -69.57%
Income Tax
% Of Pretax Income
Net Earnings -$297.0K -$27.88K -$42.82K
YoY Change 593.59% -69.56% 64.78%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$3.432K -$415.30
COMMON SHARES
Basic Shares Outstanding 86.52M 45.57M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $695.8K $382.5K $412.9K
YoY Change 68.53% 6766.25% 69881.36%
Cash & Equivalents $695.8K $382.5K $412.9K
Short-Term Investments
Other Short-Term Assets $4.690K $1.270K $730.00
YoY Change 542.47% 6.72% -97.91%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $700.5K $383.7K $413.6K
YoY Change 69.36% 5572.96% 1064.45%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $1.967M $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $1.967M $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $700.5K $383.7K $413.6K
Total Long-Term Assets $1.967M $0.00 $0.00
Total Assets $2.667M $383.7K $413.6K
YoY Change 544.9% 5572.96% 1064.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.61K $5.048K $8.170K
YoY Change 519.46% -82.44% -82.08%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $186.1K $135.4K $137.4K
YoY Change 35.4% -81.76% -79.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $186.1K $135.4K $137.4K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $186.1K $135.4K $137.4K
YoY Change 35.4% -81.76% -79.77%
SHAREHOLDERS EQUITY
Retained Earnings -$41.84M -$41.39M -$41.36M
YoY Change 1.17% 0.47% 0.62%
Common Stock $43.91M $41.63M $41.63M
YoY Change 5.46% 2.91% 2.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.481M $248.3K $276.2K
YoY Change
Total Liabilities & Shareholders Equity $2.667M $383.7K $413.6K
YoY Change 544.9% 5572.96% 1064.45%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income -$297.0K -$27.88K -$42.82K
YoY Change 593.59% -69.56% 64.78%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$173.6K -$30.44K -$62.73K
YoY Change 176.69% -711.24% 566.63%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -173.6K -30.44K -62.73K
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -173.6K -30.44K -62.73K
YoY Change 176.69% -711.24% 566.63%
FREE CASH FLOW
Cash From Operating Activities -$173.6K -$30.44K -$62.73K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 ovtz Working Capital Deficit
WorkingCapitalDeficit
-514426
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
50611
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5431
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
120098
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
32416
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
414128
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
120098
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
120098
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
CY2020Q3 us-gaap Assets
Assets
2667460
CY2019Q4 us-gaap Assets
Assets
383719
CY2020Q3 us-gaap Assets Current
AssetsCurrent
700521
CY2019Q4 us-gaap Assets Current
AssetsCurrent
383719
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
1380427
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
114169
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
695835
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
382452
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
382452
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5572
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
695835
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
412892
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
313383
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
407320
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86522569
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86522569
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86522569
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86522569
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
43908562
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
41634999
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
296973
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
43098
us-gaap Costs And Expenses
CostsAndExpenses
454725
us-gaap Costs And Expenses
CostsAndExpenses
165264
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
135484
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
129985
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-241373
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-48706
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
5499
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-556154
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3419
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-461
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1966939
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
281
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
96
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
281
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2667460
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
383719
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
186095
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
135416
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
773038
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1176702
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
114169
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-573824
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-769382
us-gaap Net Income Loss
NetIncomeLoss
-454629
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-192865
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-183279
us-gaap Net Income Loss
NetIncomeLoss
-164983
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-296973
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-42817
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
1966939
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1
414128
us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
172384
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-296973
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-43098
us-gaap Operating Income Loss
OperatingIncomeLoss
-454725
us-gaap Operating Income Loss
OperatingIncomeLoss
-165264
CY2020Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2019Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4686
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1267
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
773038
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1176702
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
93270
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
130180
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41841325
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41386696
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
83605
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43098
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
204447
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
165264
us-gaap Share Based Compensation
ShareBasedCompensation
120098
us-gaap Share Based Compensation
ShareBasedCompensation
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1380427
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1176702
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
773038
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2481365
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
248303
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-735534
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
276185
CY2020Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
414128
CY2019Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
86522569
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67022568
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78165426
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53665425

Files In Submission

Name View Source Status
0001437749-20-023178-index-headers.html Edgar Link pending
0001437749-20-023178-index.html Edgar Link pending
0001437749-20-023178.txt Edgar Link pending
0001437749-20-023178-xbrl.zip Edgar Link pending
ex_212595.htm Edgar Link pending
ex_212596.htm Edgar Link pending
ex_212597.htm Edgar Link pending
ex_212598.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ovtz-20200930.xml Edgar Link completed
ovtz-20200930.xsd Edgar Link pending
ovtz-20200930_cal.xml Edgar Link unprocessable
ovtz-20200930_def.xml Edgar Link unprocessable
ovtz-20200930_lab.xml Edgar Link unprocessable
ovtz-20200930_pre.xml Edgar Link unprocessable
ovtz20200930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending